Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Jun 2018 07:00

RNS Number : 3200S
Phoenix Group Holdings
25 June 2018
 

 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointment of two new non-executive directors: Barry O'Dwyer and Campbell Fleming, both of Standard Life Aberdeen plc ("Standard Life Aberdeen").

 

These appointments will be effective from the date of completion of the acquisition by Phoenix of Standard Life Assurance Limited and are made in accordance with the terms of Phoenix's long-term strategic partnership with Standard Life Aberdeen.

 

Barry O'Dwyer is the CEO of Standard Life Aberdeen's Pensions & Savings business ("Standard Life"). Barry has held several senior roles at Standard Life since re-joining the company in 2013, and during his initial spell at Standard Life between 1988-2008. A Fellow of the Institute of Actuaries, Barry has 30 years of experience in the insurance industry, in a career which has also included senior roles at Prudential and HBOS.

 

Campbell Fleming is the Global Head of Distribution at Aberdeen Standard Investments, the asset management business of Standard Life Aberdeen. He joined Aberdeen Asset Management in August 2016 from Columbia Threadneedle Investments where he was the Chief Executive - EMEA and Global COO. Campbell is the Chair of the Investment Association Trade Committee and previously held senior positions at JP Morgan Asset Management.

 

Both Barry and Campbell will continue in roles with Standard Life Aberdeen once the acquisition completes.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am extremely pleased that Barry O'Dwyer and Campbell Fleming will be joining the Phoenix Board following completion of the acquisition. They bring substantial experience and executive skills complementary to those of our existing directors and very relevant to our evolving strategy. Their appointment reflects the significance of the relationship that we will hold with Standard Life Aberdeen going forward, both as a major shareholder but also as our strategic partner in the new business retirement space. We look forward to working with them as we realise our role as Europe's leading life consolidator."

 

Barry O'Dwyer was a director of Standard Life plc from 1 March 2017 to 14 August 2017. No other information is required to be notified under Listing Rule 9.6.13R.

 

 

Enquiries

 

Equity Investors/Analysts:Claire Hawkins, Head of Investor Relations, Phoenix+44 (0) 20 3735 0575

 

MediaAndy Donald and Vikki Kosmalska, Maitland + 44 (0) 20 7379 5151

 

Shellie Wells, Head of Corporate Communications, Phoenix Group

+44 (0) 203 735 0922/ +44 7872 414137

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUSRWRWOANUAR
Date   Source Headline
7th Sep 20229:00 amRNSDirector/PDMR Shareholding
31st Aug 20225:00 pmRNSTotal Voting Rights
30th Aug 20224:30 pmRNSDirector/PDMR Shareholding
18th Aug 20225:00 pmRNSDirector/PDMR Shareholding
16th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS2022 Half-Year Results
9th Aug 20224:30 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSPhoenix Group to acquire Sun Life UK
29th Jul 20224:00 pmRNSTotal Voting Rights
27th Jul 20223:45 pmRNSHolding(s) in Company
27th Jul 20223:31 pmRNSHolding(s) in Company
7th Jul 20224:45 pmRNSDirector/PDMR Shareholding
1st Jul 20222:00 pmRNSTotal Voting Rights
30th Jun 20224:30 pmRNSBlock Listing Return
29th Jun 20224:00 pmRNSBoard Changes Announcement
27th Jun 20223:15 pmRNSBlocklisting Application Announcement
9th Jun 20223:30 pmRNSDirector/PDMR Shareholding
31st May 20229:30 amRNSTotal Voting Rights
30th May 202211:00 amRNSBlock Listing Application
25th May 20223:00 pmRNSDirector/PDMR Shareholding
16th May 20224:30 pmRNSDirector/PDMR Shareholding
9th May 20223:00 pmRNSDirector/PDMR Shareholding
9th May 20222:15 pmRNSBoard Changes
5th May 20221:14 pmRNSResult of AGM
29th Apr 20225:00 pmRNSTotal Voting Rights
20th Apr 20226:30 pmRNSDirector/PDMR Shareholding
11th Apr 20226:00 pmRNSDirector/PDMR Shareholding
7th Apr 20224:45 pmRNSDirector/PDMR Shareholding
6th Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSTotal Voting Rights
30th Mar 20222:00 pmRNSDirector/PDMR Shareholding
25th Mar 20225:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:00 pmRNSNotice of AGM
16th Mar 20226:27 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNS2021 Annual Financial Report
9th Mar 202211:30 amRNSDirector/PDMR Shareholding
8th Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20224:30 pmRNSTotal Voting Rights
23rd Feb 20227:00 amRNSBoard Changes
11th Feb 20225:15 pmRNSDirector/PDMR Shareholding
11th Feb 202212:00 pmRNSDirector/PDMR Shareholding
9th Feb 20229:00 amRNSDirector/PDMR Shareholding
7th Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.